-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QIgMuPUnsPgWxzrda7+qR8K5h3S1HSASvv002QQfxuzBzZy+LE55TixTgbEtSg27 AtTVTWcSEZZpUyeeFXVnMg== 0001144204-10-051837.txt : 20101001 0001144204-10-051837.hdr.sgml : 20101001 20101001060131 ACCESSION NUMBER: 0001144204-10-051837 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20101001 DATE AS OF CHANGE: 20101001 GROUP MEMBERS: D. E. SHAW & CO., L.P. GROUP MEMBERS: DAVID E. SHAW SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ENDO PHARMACEUTICALS HOLDINGS INC CENTRAL INDEX KEY: 0001100962 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134022871 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-59365 FILM NUMBER: 101100539 BUSINESS ADDRESS: STREET 1: 100 ENDO BOULEVARD CITY: CHADDS FORD STATE: PA ZIP: 19317 BUSINESS PHONE: 6105589800 MAIL ADDRESS: STREET 1: 100 ENDO BOULEVARD CITY: CHADDS FORD STATE: PA ZIP: 19317 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: D. E. Shaw Valence Portfolios, L.L.C. CENTRAL INDEX KEY: 0001294704 IRS NUMBER: 134046559 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 120 WEST FORTY-FIFTH STREET STREET 2: 39TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: (212) 478-0000 MAIL ADDRESS: STREET 1: 120 WEST FORTY-FIFTH STREET STREET 2: 39TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 SC 13D/A 1 v197938_sc13da.htm Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 11)*

ENDO Pharmaceuticals Holdings Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class Securities)


29264F205

 
D. E. Shaw & Co., L.P.
Attn:  Compliance Department
120 West Forty-Fifth Street
Floor 39, Tower 45
New York, NY 10036
212-478-0000

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communication)


September 27, 2010

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
CUSIP No.
29264F205
1
Name of Reporting Person.
I.R.S. IDENTIFICATION
 
D. E. Shaw Valence Portfolios, L.L.C.
FEIN 13-4046559
2
Check the Appropriate Box if a Member of a Group (SeeInstructions)
(a) o
(b) o
3
SEC Use Only
 
 
4
Source of Funds (See Instructions)
 
WC
5
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)  o
 
6
Citizenship or Place of Organization
 
Delaware
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
 
7
Sole Voting Power
 
-0-
8
Shared Voting Power
 
5,083,041
9
Sole Dispositive Power
 
-0-
10
Shared Dispositive Power
 
5,083,041
11
Aggregate Amount Beneficially Owned by Each Reporting Person
 
5,083,041
12
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
 
 
13
Percent of Class Represented by Amount in Row (11)
 
4.4%
14
Type of Reporting Person (See Instructions)
 
OO
 

 
CUSIP No.
29264F205
1
Name of Reporting Person.
I.R.S. IDENTIFICATION
 
D. E. Shaw & Co., L.P.
FEIN 13-3695715
2
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) o
(b) o
3
SEC Use Only
 
 
4
Source of Funds (See Instructions)
 
AF
5
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)  o
 
6
Citizenship or Place of Organization
 
Delaware
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
 
7
Sole Voting Power
 
-0-
8
Shared Voting Power
 
5,093,056
9
Sole Dispositive Power
 
-0-
10
Shared Dispositive Power
 
5,093,056
11
Aggregate Amount Beneficially Owned by Each Reporting Person
 
5,093,056
12
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
 
 
13
Percent of Class Represented by Amount in Row (11)
 
4.4%
14
Type of Reporting Person (See Instructions)
 
IA, PN
 

 
CUSIP No.
29264F205
1
Name of Reporting Person.
I.R.S. IDENTIFICATION
 
David E. Shaw
2
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) o
(b) o
3
SEC Use Only
 
 
4
Source of Funds (See Instructions)
 
AF
5
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)  o
 
6
Citizenship or Place of Organization
 
United States
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
 
7
Sole Voting Power
 
-0-
8
Shared Voting Power
 
5,093,056
9
Sole Dispositive Power
 
-0-
10
Shared Dispositive Power
 
5,093,056
11
Aggregate Amount Beneficially Owned by Each Reporting Person
 
5,093,056
12
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
 
 
13
Percent of Class Represented by Amount in Row (11)
 
4.4%
14
Type of Reporting Person (See Instructions)

IN
 

AMENDMENT NO. 11 TO SCHEDULE 13D

This Amendment No. 11 to Schedule 13D amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on July 30, 2007, as amended by Amendment No. 1 to Schedule 13D filed with the SEC on October 12, 2007, by Amendment No. 2 to Schedule 13D filed with the SEC on November 21, 2007, by Amendment No. 3 to Schedule 13D filed with the SEC on December 21, 2007, by Amendment No. 4 to Schedule 13D filed with the SEC on February 28, 2008, by Amendment No. 5 to Schedule 13D filed with the SEC on May 2, 2008, by Amendment No. 6 to Schedule 13D files with the SEC on February 17, 2009, by Amendment No. 7 to Schedule 13D filed with the SEC on March 11, 2009, by Amendment No. 8 to Schedule 13D filed with the SEC on August 28, 2009, by Amendment No. 9 to Schedule 13D filed with the SEC on October 15, 2009, and by Amendment No. 10 to Schedule 13D filed with the SEC on March 23, 2010  (as amended, the “Schedule 13D”).  Capitalized terms used herein which are not defined herein have the meanings given to such terms in the Schedule 13D.  Except as otherwise provided herein, all Items of the Schedule 13D remain unchanged.

Item 5.
Interest in Securities of the Issuer

Item 5 of the 13D is hereby supplemented as follows:
 
(a), (b) Based upon the Issuer’s Form 10-Q, filed with the Securities and Exchange Commission on August 2, 2010, there were 115,414,861 Common Shares issued and outstanding as of July 22, 2010.  The 5,083,041 Common Shares beneficially owned by Valence (the “Valence Shares”) represent approximately 4.4% of the Common Shares issued and outstanding. The 5,093,056 Common Shares beneficially owned by DESCO LP (the “Subject Shares”) represent approximately 4.4% of the Common Shares issued and outstanding.  The Subject Shares are comprised of (i) the Valence Shares, (ii) 10 Common Shares beneficially owned by Synoptic (the “Synoptic Shares”), (iii) 3,778 Common Shares beneficially owned by D. E. Shaw Oculus Portfolios, L.L.C., a Delaware limited liability company (“Oculus”) (the “Oculus Shares”), (iv) 3,827 Common Shares beneficially owned by D. E. Shaw Heliant Portfolios, L.L.C., a Delaware limited liability company (“Heliant”) (the “Heliant Shares”), and (iv) 2,400 Common Shares under the management of DESIM LLC (the “DESIM Shares”).
 
Valence has the power to vote or to direct the vote of (and the power to dispose or direct the disposition of) the Valence Shares.  Synoptic has the power to vote or to direct the vote of (and the power to dispose or direct the disposition of) the Synoptic Shares.  Oculus has the power to vote or to direct the vote of (and the power to dispose or direct the disposition of) the Oculus Shares.  Heliant has the power to vote or to direct the vote of (and the power to dispose or direct the disposition of) the Heliant Shares.  DESIM LLC has the power to vote or to direct the vote of (and the power to dispose or direct the disposition of) the DESIM Shares.  Valence disclaims beneficial ownership of the Synoptic Shares, Oculus Shares, Heliant Shares, and DESIM Shares; Synoptic disclaims beneficial ownership of the Valence Shares, Oculus Shares, Heliant Shares, and DESIM Shares; Oculus disclaims beneficial ownership of the Valence Shares, Synoptic Shares, Heliant Shares, and DESIM Shares; Heliant disclaims beneficial ownership of the Valence Shares, Synoptic Shares, Oculus Shares, and DESIM Shares; and DESIM LLC disclaims beneficial ownership of the Valence Shares, Synoptic Shares, Oculus Shares, and Heliant Shares.
 

 
DESCO LP, as managing member and investment adviser of Valence, investment adviser of Synoptic and Oculus, and managing member of DESIM LLC and D. E. Shaw Heliant Adviser, L.L.C., the investment adviser of Heliant, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Valence Shares, Synoptic Shares, Oculus Shares, Heliant Shares, and DESIM Shares.  DESCO LLC, as the managing member of Synoptic, Oculus, and Heliant, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Synoptic Shares, Oculus Shares, and Heliant Shares.  As managing member of DESCO LLC, DESCO II Inc. may be deemed to have the shared power to vote or to direct the vote of (and the shared power to dispose or direct the disposition of) the Synoptic Shares, Oculus Shares, and Heliant Shares.  As general partner of DESCO LP, DESCO Inc. may be deemed to have the shared power to vote or to direct the vote of (and the shared power to dispose or direct the disposition of) the Valence Shares, Synoptic Shares, Oculus Shares, Heliant Shares, and DESIM Shares.  None of DESCO LP, DESCO LLC, DESCO Inc., or DESCO II Inc. owns any Common Shares directly, and each such entity disclaims beneficial ownership of the Subject Shares.
 
David E. Shaw does not own any shares directly. By virtue of David E. Shaw’s position as President and sole shareholder of DESCO Inc., which is the general partner of DESCO LP, which in turn is the managing member and investment adviser of Valence, the investment adviser of Synoptic and Oculus, and the managing member of DESIM LLC and D. E. Shaw Heliant Adviser, L.L.C., the investment adviser of Heliant, and by virtue of David E. Shaw’s position as President and sole shareholder of DESCO II Inc., which is the managing member of DESCO LLC, which in turn is the managing member of Synoptic, Oculus, and Heliant, David E. Shaw may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Subject Shares.  David E. Shaw disclaims beneficial ownership of the Subject Shares.
 
As of the date hereof, neither any Reporting Person nor, to the best knowledge of any Reporting Person, any of the persons set forth in Item 2 owns any Common Shares other than those set forth in this Item 5.

(c) The trading dates, number of Common Shares purchased or sold, and the price per share for all transactions by the Reporting Persons in the Common Shares from July 30, 2010 through September 30, 2010, which were all brokered transactions, are set forth below:
 
Name
Date
Price per Share1 
Number of Shares Purchased/(Sold)
Heliant
8/10/2010
25.732
200
Oculus
8/10/2010
25.733
800
Oculus
8/10/2010
25.734
(33,397)
Synoptic
8/10/2010
25.775
3,722
Synoptic
8/10/2010
25.786
(2,528)
_____________
1 Where weighted average price is used for the reported transactions, the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission, full information regarding the number of shares purchased or sold at each separate price. 
2 A weighted average price based on prices ranging from $25.48 to $25.98. 
3 A weighted average price based on prices ranging from $25.48 to $25.95. 
4 A weighted average price based on prices ranging from $25.38 to $25.97. 
5 A weighted average price based on prices ranging from $25.41 to $26.04. 
6 A weighted average price based on prices ranging from $25.61 to $26.03.
 

 
Name
Date
Price per Share1 
Number of Shares Purchased/(Sold)
Oculus
8/11/2010
25.157
(2,030)
Synoptic
8/11/2010
25.188
1,301
Synoptic
8/11/2010
25.269
(1,920)
Synoptic
8/12/2010
25.0310
(800)
Synoptic
8/12/2010
25.1011
817
Synoptic
8/13/2010
24.8712
900
Synoptic
8/13/2010
24.9113
(406)
DESIM
8/16/2010
24.9714
(200)
Heliant
8/16/2010
24.99
100
Synoptic
8/16/2010
25.0315
(546)
Synoptic
8/16/2010
25.0616
138
DESIM
8/17/2010
25.6417
(1,100)
Heliant
8/17/2010
25.7818
200
Oculus
8/17/2010
26.12
100
Synoptic
8/17/2010
25.8119
(2,306)
Synoptic
8/17/2010
25.8420
2,186
Synoptic
8/17/2010
26.1821
(1,100)
DESIM
8/18/2010
28.2822
(2,102)
DESIM
8/18/2010
28.8623
(200)
Heliant
8/18/2010
28.1624
200
Oculus
8/18/2010
28.3025
400
Oculus
8/18/2010
28.6726
(4,900)
Synoptic
8/18/2010
27.7927
4,900
Synoptic
8/18/2010
27.9528
(9,071)
Synoptic
8/18/2010
28.4929
14,523
Synoptic
8/18/2010
28.5930
(7,548)
Synoptic
8/18/2010
29.0931
102
Valence
8/18/2010
26.9432
(25,100)
Valence
8/18/2010
28.1633
(74,900)
Valence
8/18/2010
29.0734
(2,700)
DESIM
8/19/2010
28.8735
(1,581)
Heliant
8/19/2010
28.5936
500
Oculus
8/19/2010
28.7337
2,200
Oculus
8/19/2010
29.0138
(1,300)
Synoptic
8/19/2010
28.7539
5,086
Synoptic
8/19/2010
28.8940
(6,974)
Valence
8/19/2010
28.5741
(100,000)
DESIM
8/20/2010
28.9742
(1,000)
Oculus
8/20/2010
28.9243
(700)
Oculus
8/20/2010
29.20
100
Synoptic
8/20/2010
28.9544
4,038
Synoptic
8/20/2010
28.9745
(4,398)
Valence
8/20/2010
29.0546
(98,400)
DESIM
8/23/2010
29.1747
(300)
Heliant
8/23/2010
29.2748
300
Oculus
8/23/2010
28.87
(100)
Synoptic
8/23/2010
29.0349
1,861
Synoptic
8/23/2010
29.0350
(1,594)
Valence
8/23/2010
29.2151
(20,000)
DESIM
8/24/2010
28.2352
(400)
Heliant
8/24/2010
28.1953
200
_____________
7 A weighted average price based on prices ranging from $25.08 to $25.23. 
8 A weighted average price based on prices ranging from $25.02 to $25.38. 
9 A weighted average price based on prices ranging from $25.08 to $25.46. 
10 A weighted average price based on prices ranging from $24.88 to $25.12. 
11 A weighted average price based on prices ranging from $24.98 to $25.22. 
12 A weighted average price based on prices ranging from $24.81 to $24.91. 
13 A weighted average price based on prices ranging from $24.81 to $24.92. 
14 A weighted average price based on prices ranging from $24.83 to $25.10. 
15 A weighted average price based on prices ranging from $24.81 to $25.19. 
16 A weighted average price based on prices ranging from $24.99 to $25.09. 
17 A weighted average price based on prices ranging from $25.27 to $26.16. 
18 A weighted average price based on prices ranging from $25.44 to $26.12. 
19 A weighted average price based on prices ranging from $25.13 to $26.11. 
20 A weighted average price based on prices ranging from $25.28 to $26.27. 
21 A weighted average price based on prices ranging from $26.14 to $26.28. 
22 A weighted average price based on prices ranging from $27.77 to $28.73. 
23 A weighted average price based on prices ranging from $28.80 to $28.91. 
24 A weighted average price based on prices ranging from $27.92 to $28.40. 
25 A weighted average price based on prices ranging from $27.94 to $28.80. 
26 A weighted average price based on prices ranging from $28.38 to $29.13. 
27 A weighted average price based on prices ranging from $26.95 to $27.93. 
28 A weighted average price based on prices ranging from $27.34 to $28.30. 
29 A weighted average price based on prices ranging from $27.96 to $28.92. 
30 A weighted average price based on prices ranging from $28.35 to $29.10. 
31 A weighted average price based on prices ranging from $28.97 to $29.09. 
32 A weighted average price based on prices ranging from $26.20 to $27.07. 
33 A weighted average price based on prices ranging from $28.00 to $28.26. 
34 A weighted average price based on prices ranging from $29.02 to $29.12. 
35 A weighted average price based on prices ranging from $28.58 to $29.19. 
36 A weighted average price based on prices ranging from $28.42 to $28.76. 
37 A weighted average price based on prices ranging from $28.44 to $29.12. 
38 A weighted average price based on prices ranging from $28.96 to $29.05. 
39 A weighted average price based on prices ranging from $28.45 to $29.15. 
40 A weighted average price based on prices ranging from $28.43 to $29.21. 
41 A weighted average price based on prices ranging from $28.46 to $28.77. 
42 A weighted average price based on prices ranging from $28.87 to $29.01. 
43 A weighted average price based on prices ranging from $28.82 to $29.23. 
44 A weighted average price based on prices ranging from $28.79 to $29.15. 
45 A weighted average price based on prices ranging from $28.79 to $29.16. 
46 A weighted average price based on prices ranging from $29.00 to $29.31. 
47 A weighted average price based on prices ranging from $29.01 to $29.41. 
48 A weighted average price based on prices ranging from $29.03 to $29.40. 
49 A weighted average price based on prices ranging from $28.84 to $29.54. 
50 A weighted average price based on prices ranging from $28.84 to $29.41. 
51 A weighted average price based on prices ranging from $29.00 to $29.43. 
52 A weighted average price based on prices ranging from $28.10 to $28.36. 
53 A weighted average price based on prices ranging from $28.16 to $28.21.
 

 
Name
Date
Price per Share1 
Number of Shares Purchased/(Sold)
Synoptic
8/24/2010
28.1454
5,493
Synoptic
8/24/2010
28.1755
(3,406)
DESIM
8/25/2010
28.1756
(400)
Heliant
8/25/2010
27.93
200
Synoptic
8/25/2010
28.0757
2,389
Synoptic
8/25/2010
28.2258
(4,403)
Synoptic
8/25/2010
28.7959
200
DESIM
8/26/2010
28.3160
(300)
Synoptic
8/26/2010
28.2561
(6,019)
Synoptic
8/26/2010
28.3362
4,745
DESIM
8/27/2010
28.1463
(700)
Synoptic
8/27/2010
28.1664
2,618
Synoptic
8/27/2010
28.2065
(1,300)
DESIM
8/30/2010
27.6666
(800)
Heliant
8/30/2010
27.9267
300
Synoptic
8/30/2010
27.6768
1,006
Synoptic
8/30/2010
27.7169
(1,351)
DESIM
8/31/2010
27.4770
(200)
Heliant
8/31/2010
27.36
100
Synoptic
8/31/2010
27.3571
4,383
Synoptic
8/31/2010
27.4072
(2,339)
DESIM
9/1/2010
27.8473
(200)
Heliant
9/1/2010
27.8274
200
Synoptic
9/1/2010
27.8875
3,073
Synoptic
9/1/2010
27.9776
(2,915)
DESIM
9/2/2010
27.9177
(300)
Heliant
9/2/2010
27.91
100
Synoptic
9/2/2010
27.9778
(1,671)
Synoptic
9/2/2010
28.0879
782
DESIM
9/3/2010
28.6880
(300)
Heliant
9/3/2010
28.7081
300
Synoptic
9/3/2010
28.7082
3,223
Synoptic
9/3/2010
28.7583
(4,661)
DESIM
9/7/2010
28.4184
(300)
Heliant
9/7/2010
28.60
100
Oculus
9/7/2010
28.46
(100)
Synoptic
9/7/2010
28.2485
(1,931)
Synoptic
9/7/2010
28.2986
1,929
DESIM
9/8/2010
28.3587
(200)
Oculus
9/8/2010
28.3588
(200)
Synoptic
9/8/2010
28.3789
4,941
Synoptic
9/8/2010
28.4390
(5,126)
DESIM
9/9/2010
28.65
(200)
Synoptic
9/9/2010
28.4591
5,164
Synoptic
9/9/2010
28.5892
(3,493)
Valence
9/9/2010
28.5493
(35,000)
DESIM
9/10/2010
28.4294
(200)
Oculus
9/10/2010
28.4895
(273)
Synoptic
9/10/2010
28.5196
(3,345)
Synoptic
9/10/2010
28.5297
1,509
Valence
9/10/2010
28.4898
(100,000)
_____________
54 A weighted average price based on prices ranging from $28.03 to $28.43. 
55 A weighted average price based on prices ranging from $28.04 to $28.42. 
56 A weighted average price based on prices ranging from $27.83 to $28.67. 
57 A weighted average price based on prices ranging from $27.75 to $28.66. 
58 A weighted average price based on prices ranging from $27.76 to $28.71. 
59 A weighted average price based on prices ranging from $28.78 to $28.79. 
60 A weighted average price based on prices ranging from $28.19 to $28.50. 
61 A weighted average price based on prices ranging from $28.10 to $28.41. 
62 A weighted average price based on prices ranging from $28.10 to $28.56. 
63 A weighted average price based on prices ranging from $28.06 to $28.29. 
64 A weighted average price based on prices ranging from $28.00 to $28.35. 
65 A weighted average price based on prices ranging from $28.03 to $28.36. 
66 A weighted average price based on prices ranging from $27.60 to $27.96. 
67 A weighted average price based on prices ranging from $27.88 to $28.01. 
68 A weighted average price based on prices ranging from $27.54 to $27.77. 
69 A weighted average price based on prices ranging from $27.55 to $27.80. 
70 A weighted average price based on prices ranging from $27.32 to $27.61. 
71 A weighted average price based on prices ranging from $27.17 to $27.68. 
72 A weighted average price based on prices ranging from $27.17 to $27.65. 
73 A weighted average price based on prices ranging from $27.70 to $27.97. 
74 A weighted average price based on prices ranging from $27.68 to $27.95. 
75 A weighted average price based on prices ranging from $27.85 to $28.06. 
76 A weighted average price based on prices ranging from $27.55 to $28.20. 
77 A weighted average price based on prices ranging from $27.81 to $28.08. 
78 A weighted average price based on prices ranging from $27.77 to $28.08. 
79 A weighted average price based on prices ranging from $27.94 to $28.12. 
80 A weighted average price based on prices ranging from $28.56 to $28.77. 
81 A weighted average price based on prices ranging from $28.56 to $28.85. 
82 A weighted average price based on prices ranging from $28.49 to $28.91. 
83 A weighted average price based on prices ranging from $28.47 to $28.93. 
84 A weighted average price based on prices ranging from $28.25 to $28.52. 
85 A weighted average price based on prices ranging from $28.07 to $28.65. 
86 A weighted average price based on prices ranging from $28.06 to $28.56. 
87 A weighted average price based on prices ranging from $28.33 to $28.36. 
88 A weighted average price based on prices ranging from $28.33 to $28.37. 
89 A weighted average price based on prices ranging from $28.30 to $28.53. 
90 A weighted average price based on prices ranging from $28.25 to $28.57. 
91 A weighted average price based on prices ranging from $28.33 to $28.67. 
92 A weighted average price based on prices ranging from $28.34 to $28.72. 
93 A weighted average price based on prices ranging from $28.36 to $28.72. 
94 A weighted average price based on prices ranging from $28.33 to $28.51. 
95 A weighted average price based on prices ranging from $28.45 to $28.52. 
96 A weighted average price based on prices ranging from $28.42 to $28.58. 
97 A weighted average price based on prices ranging from $28.40 to $28.55. 
98 A weighted average price based on prices ranging from $28.30 to $28.55.
 

 
Name  Date
Price per Share1 
Number of Shares Purchased/(Sold)
DESIM
9/13/2010
28.6699
(200)
Synoptic
9/13/2010
28.65100
(1,375)
Synoptic
9/13/2010
28.66101
2,019
Valence
9/13/2010
28.67102
(70,002)
DESIM
9/14/2010
29.16103
(200)
Heliant
9/14/2010
29.63104
200
Synoptic
9/14/2010
29.30105
4,002
Synoptic
9/14/2010
29.31106
(5,015)
Synoptic
9/14/2010
29.82
100
Valence
9/14/2010
29.36107
(193,238)
DESIM
9/15/2010
29.51
(100)
Heliant
9/15/2010
29.72
100
Synoptic
9/15/2010
29.44108
(4,524)
Synoptic
9/15/2010
29.48109
5,005
Valence
9/15/2010
29.64110
(200,000)
DESIM
9/16/2010
29.13
(100)
Heliant
9/16/2010
29.64
27
Oculus
9/16/2010
29.51111
173
Synoptic
9/16/2010
29.13112
1,285
Synoptic
9/16/2010
29.23113
(2,494)
Valence
9/16/2010
29.25114
(69,465)
Synoptic
9/17/2010
29.48115
2,751
Synoptic
9/17/2010
29.63116
(2,000)
Valence
9/17/2010
29.47117
(200,000)
Synoptic
9/20/2010
29.49118
3,137
Synoptic
9/20/2010
29.51119
(3,126)
Valence
9/20/2010
29.49120
(150,000)
DESIM
9/21/2010
29.04
(100)
Synoptic
9/21/2010
28.97121
7,513
Synoptic
9/21/2010
28.99122
(6,867)
DESIM
9/22/2010
28.68
(100)
Synoptic
9/22/2010
28.86123
(3,260)
Synoptic
9/22/2010
28.88124
2,864
Valence
9/22/2010
29.07125
(15,000)
DESIM
9/23/2010
29.75126
(200)
Synoptic
9/23/2010
29.67127
(4,989)
Synoptic
9/23/2010
29.68128
4,579
Valence
9/23/2010
29.77129
(134,684)
DESIM
9/24/2010
30.41130
(200)
Synoptic
9/24/2010
30.40131
4,125
Synoptic
9/24/2010
30.43132
(2,448)
Valence
9/24/2010
30.47133
(100,000)
Synoptic
9/27/2010
30.34134
(826)
Synoptic
9/27/2010
30.45135
435
Valence
9/27/2010
30.46136
(250,000)
DESIM
9/28/2010
33.39137
(300)
Synoptic
9/28/2010
33.39138
14,885
Synoptic
9/28/2010
33.49139
(14,328)
Synoptic
9/28/2010
34.04140
700
Synoptic
9/28/2010
34.14
(200)
Valence
9/28/2010
33.44141
(150,000)
_____________
99 A weighted average price based on prices ranging from $28.63 to $28.69. 
100 A weighted average price based on prices ranging from $28.56 to $28.78. 
101 A weighted average price based on prices ranging from $28.61 to $28.77. 
102 A weighted average price based on prices ranging from $28.60 to $28.76. 
103 A weighted average price based on prices ranging from $28.90 to $29.41. 
104 A weighted average price based on prices ranging from $29.40 to $29.86. 
105 A weighted average price based on prices ranging from $28.81 to $29.76. 
106 A weighted average price based on prices ranging from $28.98 to $29.89. 
107 A weighted average price based on prices ranging from $28.85 to $29.84. 
108 A weighted average price based on prices ranging from $29.20 to $29.73. 
109 A weighted average price based on prices ranging from $29.15 to $29.73. 
110 A weighted average price based on prices ranging from $29.50 to $29.73. 
111 A weighted average price based on prices ranging from $29.41 to $29.64. 
112 A weighted average price based on prices ranging from $28.98 to $29.47. 
113 A weighted average price based on prices ranging from $29.01 to $29.64. 
114 A weighted average price based on prices ranging from $29.03 to $29.65. 
115 A weighted average price based on prices ranging from $28.82 to $29.69. 
116 A weighted average price based on prices ranging from $29.52 to $29.66. 
117 A weighted average price based on prices ranging from $29.03 to $29.75. 
118 A weighted average price based on prices ranging from $29.38 to $29.59. 
119 A weighted average price based on prices ranging from $29.39 to $29.61. 
120 A weighted average price based on prices ranging from $29.40 to $29.71. 
121 A weighted average price based on prices ranging from $28.73 to $29.10. 
122 A weighted average price based on prices ranging from $28.69 to $29.13. 
123 A weighted average price based on prices ranging from $28.62 to $29.28. 
124 A weighted average price based on prices ranging from $28.61 to $29.12. 
125 A weighted average price based on prices ranging from $29.05 to $29.16. 
126 A weighted average price based on prices ranging from $29.39 to $30.10. 
127 A weighted average price based on prices ranging from $29.31 to $30.17. 
128 A weighted average price based on prices ranging from $29.35 to $30.16. 
129 A weighted average price based on prices ranging from $29.30 to $30.15. 
130 A weighted average price based on prices ranging from $30.19 to $30.62. 
131 A weighted average price based on prices ranging from $29.97 to $30.74. 
132 A weighted average price based on prices ranging from $30.25 to $30.68. 
133 A weighted average price based on prices ranging from $30.25 to $30.67. 
134 A weighted average price based on prices ranging from $30.22 to $30.49. 
135 A weighted average price based on prices ranging from $30.32 to $30.54. 
136 A weighted average price based on prices ranging from $30.30 to $30.60. 
137 A weighted average price based on prices ranging from $33.08 to $33.72. 
138 A weighted average price based on prices ranging from $33.01 to $34.01. 
139 A weighted average price based on prices ranging from $33.06 to $34.03.
140 A weighted average price based on prices ranging from $34.02 to $34.14. 
141 A weighted average price based on prices ranging from $33.06 to $33.99.
 

 
Name Date
Price per Share1 
Number of Shares Purchased/(Sold)
DESIM
9/29/2010
33.00142
(300)
Oculus
9/29/2010
33.52143
300
Synoptic
9/29/2010
33.12144
(8,913)
Synoptic
9/29/2010
33.14145
8,096
Synoptic
9/29/2010
33.66146
1,142
Synoptic
9/29/2010
33.71147
(1,004)
Valence
9/29/2010
33.16148
(16,758)
Valence
9/29/2010
33.67149
(35,242)
DESIM
9/30/2010
33.34150
(200)
Synoptic
9/30/2010
33.31151
(5,238)
Synoptic
9/30/2010
33.37152
4,274
Synoptic
9/30/2010
33.60
100
Valence
9/30/2010
33.44153
(100,000)
_____________
143 A weighted average price based on prices ranging from $33.35 to $33.61. 
144 A weighted average price based on prices ranging from $32.55 to $33.55. 
145 A weighted average price based on prices ranging from $32.57 to $33.56. 
146 A weighted average price based on prices ranging from $33.58 to $33.72. 
147 A weighted average price based on prices ranging from $33.61 to $33.71. 
148 A weighted average price based on prices ranging from $32.56 to $33.56. 
149 A weighted average price based on prices ranging from $33.57 to $33.73.
150 A weighted average price based on prices ranging from $33.08 to $33.60.
151 A weighted average price based on prices ranging from $32.60 to $33.57.
152 A weighted average price based on prices ranging from $32.59 to $33.59.
153 A weighted average price based on prices ranging from $33.25 to $33.60.
 
(d) No person other than the Reporting Persons,  Oculus, Heliant, and DESIM have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Shares set forth above.
 
(e) The Reporting Persons ceased to be the beneficial owners of five percent or more of the outstanding Common Shares as of September 23, 2010.
 
Item 6.
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
 
Item 6 of the Schedule 13D is hereby amended and restated in its entirety as follows:
 
Valence maintains an open short position of 35,855 Common Shares.
 
Except for the matters described herein, neither the Reporting Persons nor, to the best knowledge of any Reporting Person, any of the persons listed in Item 2 has any contract, arrangement, understanding or relationship with any person with respect to any securities of the Issuer as of September 30, 2010.
 
Item 7.
Material to be Filed as Exhibits
 
Exhibit 1
Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co., Inc., in favor of the signatories hereto, among others, dated October 24, 2007.
 

 
SIGNATURE

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete, and correct.

Dated:  September 30, 2010



 
D. E. SHAW VALENCE PORTFOLIOS, L.L.C.
 
 
By:
/s/ Rochelle Elias
   
Rochelle Elias
   
Authorized Signatory
     
     
 
D. E. SHAW & CO., L.P.
   
 
By:
/s/ Rochelle Elias
   
Rochelle Elias
   
Chief Compliance Officer
     
     
 
DAVID E. SHAW
     
 
By:
/s/ Rochelle Elias
   
Rochelle Elias
   
Attorney-in-Fact for David E. Shaw
 

 
EX-1 2 v197938_ex-1.htm
Exhibit 1

POWER OF ATTORNEY
FOR CERTAIN FILINGS
UNDER THE SECURITIES EXCHANGE ACT OF 1934


I, David E. Shaw, hereby make, constitute, and appoint each of:

Anne Dinning,

Rochelle Elias,

Julius Gaudio,

John Liftin,

Louis Salkind,

Stuart Steckler,

Maximilian Stone, and

Eric Wepsic,

acting individually, as my agent and attorney-in-fact, with full power of substitution, for the purpose of, from time to time, executing in my name and/or my capacity as President of D. E. Shaw & Co., Inc. (acting for itself or as the general partner of D. E. Shaw & Co., L. P. and general partner, managing member, or manager of other entities, any of which in turn may be acting for itself or other entities) all documents, certificates, instruments, statements, other filings, and amendments to the foregoing (collectively, “documents”) determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including without limitation Forms 3, 4, 5, and 13F and Schedules 13D and 13G required to be filed with the Securities and Exchange Commission; and delivering, furnishing, or filing any such documents to or with the appropriate governmental or regulatory authority.  Any such determination shall be conclusively evidenced by such person’s execution, delivery, furnishing, and/or filing of the applicable document.

This power of attorney shall be valid from the date hereof and replaces the power granted on February 24, 2004, which is hereby cancelled.

IN WITNESS HEREOF, I have executed this instrument as of the date set forth below.

Date:  October 24, 2007

DAVID E. SHAW, as President of
D. E. Shaw & Co., Inc.
/s/ David E. Shaw
New York, New York
 
 
 

 
-----END PRIVACY-ENHANCED MESSAGE-----